Citigroup Has Lowered Expectations for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its target price decreased by research analysts at Citigroup from $2.50 to $1.75 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “sell” rating on the stock. Citigroup’s price objective indicates a potential upside of 1.74% from the company’s previous close.

A number of other analysts have also issued reports on the company. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Benchmark reissued a “buy” rating and set a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Stifel Nicolaus cut their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $6.38.

agilon health Stock Down 8.5 %

NYSE AGL opened at $1.72 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52 week low of $1.70 and a 52 week high of $13.76. The business’s fifty day simple moving average is $3.09 and its 200-day simple moving average is $4.88. The firm has a market cap of $708.67 million, a PE ratio of -1.83 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the prior year, the company posted ($0.06) earnings per share. As a group, equities analysts anticipate that agilon health will post -0.35 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AGL. Vanguard Group Inc. raised its stake in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after buying an additional 371,537 shares in the last quarter. Capital International Investors raised its position in agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Citigroup Inc. lifted its holdings in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock worth $7,252,000 after purchasing an additional 174,883 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.